Rafferty Asset Management, LLC

Position in NKTR — Nektar Therapeutics

CIK 1389426 New York, NY

Position in NKTR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$244,265

+$212,757 QoQ

Shares Held

3,499

+276.6% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#177

of 239 holders

Holding Since

Jun 2020

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $331,711,589 across 163 Biotechnology names. NKTR ranks #141 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	65,798	$32,683,840
2	REGN	Regeneron Pharmaceuticals, Inc.	38,534	$24,027,490
3	ALNY	Alnylam Pharmaceuticals, Inc.	55,332	$16,656,591
4	MRNA	Moderna, Inc.	111,906	$7,836,777
5	INCY	Incyte Corp	44,663	$5,062,997
6	APGE	Apogee Therapeutics, Inc.	33,369	$4,429,067
7	ORKA	Oruka Therapeutics, Inc.	43,110	$4,102,778
8	KYMR	Kymera Therapeutics, Inc.	35,287	$4,046,360

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$244,265	3,499	-74.9%	Shares	Sole	2026-08-14
2022-12-31	$31,508	13,942	-58.5%	Shares	Sole	2023-02-13
2022-09-30	$107,584	33,620	-52.9%	Shares	Sole	2022-11-14
2022-06-30	$271,304	71,396	+205.5%	Shares	Sole	2022-08-12
2022-03-31	$125,985	23,374	-3.6%	Shares	Sole	2022-05-13
2021-12-31	$327,468	24,239	+46.3%	Shares	Sole	2022-02-10
2021-09-30	$297,525	16,566	+50.6%	Shares	Sole	2021-11-10
2021-06-30	$188,777	11,001	-34.1%	Shares	Sole	2021-08-10
2020-12-31	$283,883	16,699	-8.9%	Shares	Sole	2021-02-10
2020-06-30	$424,407	18,325	—	Shares	Sole	2020-08-07
No filing history on record for this holder in this stock.